NIH-funded research R01 grant

Understanding how the palate develops and what causes cleft palates

Official title: Molecular Regulation of Palate Development

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11047745 · Data updated 2026-11-12

This study is looking into how the mouth develops, especially for babies born with a submucous cleft palate, to understand what goes wrong during this process and find ways to help improve treatments.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startMarch 4, 2024
Project endDecember 31, 2028
Funding year2025
Award (this year)$664,175
NIH project number5R01DE033890-02
Project IDNIH-11047745 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are infants and children diagnosed with submucous cleft palate or other craniofacial abnormalities.

Less likely to help

Patients with cleft palates caused by non-genetic factors or those who do not have craniofacial abnormalities may not benefit from this research.

What this research studies

This research investigates the molecular mechanisms behind palate development, particularly focusing on submucous cleft palate (SMCP), a common birth defect. By examining the role of specific transcription factors and their expression patterns during embryonic development, the study aims to uncover how muscle and connective tissues in the palate are formed and regulated. The research employs advanced biological assays and genetic analysis to explore the interactions between different cell types involved in palate formation. This could lead to a better understanding of the causes of cleft palates and potential therapeutic approaches.

Why it matters

Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for cleft palate and related birth defects.

How similar studies have gone: Previous research has shown success in understanding muscle development and signaling pathways in other contexts, suggesting potential for breakthroughs in this area as well.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Jiang, Rulang — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Jiang, Rulang

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.